iBio, Inc.: accounts_receivable
| Value | {"amount": 351409, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2012-06-30) |
| Status | superseded |
| Entity | iBio, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:56:09.954965+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d632bc69-b7b6-4f69-a1b6-6fc3c631a072
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000930413-12-005739Retrieved: 2026-08-19T13:56:09.954965+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001420720/accounts-receivable/2012-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d632bc69-b7b6-4f69-a1b6-6fc3c631a072
History
- no predecessors — first report